ProMIS Neurosciences Inc (PMN)

[tex4]

As I stated yesterday, I think the newsletter had a ton of truth about it as far as the prion targeting therapy and how it is better targeting the toxic cells than anything currently out there . I think the only bs was the date of 2-14-2018 and a major announcement pending. Promis did not say anything about that date, so we will watch and see. I still think a buyout of this company would be worth at least $ 11.5 billion based on 220,000,000 ( 220 million ) shares in issue and a share price of $50. That figure is inexpensive to a large pharma if the drug PMN310 gets to market as a way to halt or slow the progression of Alzheimer's. I would like any thoughts on my calculation. I read where a drug for Alzheimer's will be worth over $ 30 billion treating patients in the USA alone. Multiply that by all the patients needing treatment throughout the world and $ 11.5 billion would seem cheap to acquire this company and their technology. I will wait as long as it takes, but the company definitely has a lot going for it at this super low share price.